Yüksel Ürün(@DrYukselUrun) 's Twitter Profileg
Yüksel Ürün

@DrYukselUrun

Prof. Medical Oncologist 🔬 @AnkaraUni 🎓 Advocate for #Diversity & #Equity 🌟 Genitourinary Cancer I 2023-2024 @ASCO Leadership Development Program

ID:2798480350

linkhttps://yukselurun.com/ calendar_today01-10-2014 17:42:21

9,5K Tweets

5,9K Followers

551 Following

Follow People
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

🔬 Immunotherapy (IO) significantly improves survival for metastatic renal cell carcinoma (mRCC) patients, compared to targeted therapies (TT)!
🔘IO shows even greater benefits for those with sarcomatoid features.
💊IO vs TT in non-sarcomatoid patients: 38.5% vs 23.5% ORR…

🔬 Immunotherapy (IO) significantly improves survival for metastatic renal cell carcinoma (mRCC) patients, compared to targeted therapies (TT)! 🔘IO shows even greater benefits for those with sarcomatoid features. 💊IO vs TT in non-sarcomatoid patients: 38.5% vs 23.5% ORR…
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

🔎🦠 A new reveals a striking fact: 4.3% of adult cancers in the US in 2017 were linked to infections. HPV leads the charge, highlighting the critical role of prevention & vaccination. ! 🎗️
JAMA Oncology OncoAlert ASCO

🔎🦠 A new #MetaAnalysis reveals a striking fact: 4.3% of adult cancers in the US in 2017 were linked to infections. HPV leads the charge, highlighting the critical role of prevention & vaccination. #Cancer #Treatment! 🎗️#HPVvaccine #EBV #PublicHealth @JAMAOnc @OncoAlert @ASCO…
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Top advances of the year: Ovarian cancer
🎗️🔬 The first ADC for platinum-resistant cases has received FDA approval, ushering in a new era of therapy.
🧬🧬Long-term studies reveal a survival benefit from PARPi maintenance.
There's hope on the horizon for improved clinical…

Top advances of the year: Ovarian cancer 🎗️🔬 The first ADC for platinum-resistant cases has received FDA approval, ushering in a new era of therapy. 🧬🧬Long-term studies reveal a survival benefit from PARPi maintenance. There's hope on the horizon for improved clinical…
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

🚀 Embrace the Future: is reshaping the mentorship landscape in 2024!
🌟 Expect collaborative projects, interactive experiences & digital engagement. Time to revamp traditional mentorship to match their pace & values. Let's adapt, connect, and thrive together!…

🚀 Embrace the Future: #GenZ is reshaping the mentorship landscape in 2024! 🌟 Expect collaborative projects, interactive experiences & digital engagement. Time to revamp traditional mentorship to match their pace & values. Let's adapt, connect, and thrive together!…
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Thank you so much Sumanta K. Pal, MD, FASCO for your continuous support towards young and aspiring medical professionals like them. It's truly inspiring to see how you embrace and encourage the next generation of doctors, fostering a nurturing environment for clinical research and development.…

account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Herkesin yüreğinde, mutluluğun tatlı sancısıyla ya da hüznün ağır yüküyle, hiç bitmeyecekmiş gibi süren, kendine özgü bir en uzun gece saklıdır.

Herkesin yüreğinde, mutluluğun tatlı sancısıyla ya da hüznün ağır yüküyle, hiç bitmeyecekmiş gibi süren, kendine özgü bir en uzun gece saklıdır.
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Ciddi Hastalıklar ve Yaşam Sonu Durumları İle İlgili Konuşmak:

Uzun yıllardır onkoloji doktoru olmama rağmen bu konuda konuşmak her zaman zordur. Elbetteki, bireysel, kültürel farklılıklar her zaman göz önünde bulundurulmalıdır. Ama ne olursa olsun kötü haber vermek, her zaman…

Ciddi Hastalıklar ve Yaşam Sonu Durumları İle İlgili Konuşmak: Uzun yıllardır onkoloji doktoru olmama rağmen bu konuda konuşmak her zaman zordur. Elbetteki, bireysel, kültürel farklılıklar her zaman göz önünde bulundurulmalıdır. Ama ne olursa olsun kötü haber vermek, her zaman…
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

🚨 New insights from 'Patient Experience, Adverse Event Reporting, and Clinical Trial Design' highlight the crucial role of low-grade AEs in cancer treatment. Patients' daily struggles matter!
🎯 Let's design trials with patient experiences at heart. 💊🔬…

🚨 New insights from 'Patient Experience, Adverse Event Reporting, and Clinical Trial Design' highlight the crucial role of low-grade AEs in cancer treatment. Patients' daily struggles matter! 🎯 Let's design trials with patient experiences at heart. #Cancer #Treatment 💊🔬…
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Bu yll dokuzuncusunu düzenlediğimiz sempozyuma davetlisiniz.
2023'ü tamamlarken klinik pratigimize etki eden çalismalari, pratigimizi degistiren güncel gelismeleri birlikte tartisiyoruz.
Ankara Üniversitesi Ankara Üniversitesi Tıp Fakültesi

Bu yll dokuzuncusunu düzenlediğimiz sempozyuma davetlisiniz. 2023'ü tamamlarken klinik pratigimize etki eden çalismalari, pratigimizi degistiren güncel gelismeleri birlikte tartisiyoruz. @AnkaraUni @Ankaratip1945 #ankara #onkoloji #kanser
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

🎗️
🔘Less frequent mammograms = equally effective for breast cancer survivors over 50.
🧬 5-year survival rates impressive! 📈
OncoAlert
prac.co/l/yo7jwjn5 via PracticeUpdate

#SABCS2023🎗️ 🔘Less frequent mammograms = equally effective for breast cancer survivors over 50. 🧬 5-year survival rates impressive! 📈 @OncoAlert prac.co/l/yo7jwjn5 via @practiceupdate
account_circle
Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo

Among academic physicians!
🔥Nearly 1 in 3 express an intention to LEAVE their institutions, highlighting a critical need for improved well-being and job satisfaction.
🔥Burnout and lack of fulfillment are key factors.
🔘This calls for a comprehensive approach to enhance the…

Among academic physicians! 🔥Nearly 1 in 3 express an intention to LEAVE their institutions, highlighting a critical need for improved well-being and job satisfaction. 🔥Burnout and lack of fulfillment are key factors. 🔘This calls for a comprehensive approach to enhance the…
account_circle